AAAAAA
Results: 1-25/32
Authors:
RUPNOW BA
ALARCON RM
GIACCIA AJ
KNOX SJ
Citation: Ba. Rupnow et al., P53 MEDIATES APOPTOSIS INDUCED BY C-MYC ACTIVATION IN HYPOXIC OR GAMMA-IRRADIATED FIBROBLASTS, Cell death and differentiation, 5(2), 1998, pp. 141-147
Authors:
YU NY
PATAWARAN M
CHEN J
PENA R
NING S
KNOX SJ
BROWN DM
JONES RE
Citation: Ny. Yu et al., RADIOPOTENTIATION WITH INTRATUMORAL FLUOROURACIL ADMINISTERED IN AN INJECTABLE GEL SYSTEM, Annals of oncology, 9, 1998, pp. 580-580
Authors:
NING SC
SHUI CX
KHAN WB
BENSON W
LACEY DL
KNOX SJ
Citation: Sc. Ning et al., EFFECTS OF KERATINOCYTE GROWTH-FACTOR ON THE PROLIFERATION AND RADIATION SURVIVAL OF HUMAN SQUAMOUS-CELL CARCINOMA CELL-LINES IN-VITRO AND IN-VIVO, International journal of radiation oncology, biology, physics, 40(1), 1998, pp. 177-187
Authors:
RUPNOW BA
MURTHA AD
CHEN E
KNOX SJ
Citation: Ba. Rupnow et al., MYC ACTIVATION REDUCES FIBROBLAST CLONOGENICITY VIA AN APOPTOTIC MECHANISM THAT CAN BE SUPPRESSED BY A SOLUBLE PARACRINE FACTOR, Cancer letters, 127(1-2), 1998, pp. 211-219
Authors:
RUPNOW BA
MURTHA AD
ALARCON RM
GIACCIA AJ
KNOX SJ
Citation: Ba. Rupnow et al., DIRECT EVIDENCE THAT APOPTOSIS ENHANCES TUMOR RESPONSES TO FRACTIONATED RADIOTHERAPY, Cancer research, 58(9), 1998, pp. 1779-1784
Authors:
RUPNOW BA
MURTHA AD
ALARCON RM
GIACCIA AJ
KNOX SJ
Citation: Ba. Rupnow et al., APOPTOTIC POTENTIAL AND CELL SENSITIVITY TO FRACTIONATED RADIOTHERAPY, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 179-179
Authors:
MURTHA AD
RUPNOW B
KNOX SJ
Citation: Ad. Murtha et al., LOW-DOSE RATE RADIATION FAVORS APOPTOSIS AS A MECHANISM OF CELL-DEATH, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 242-242
Authors:
KNOX SJ
GORIS ML
DAVIS TA
TRISLER KD
SAAL J
LEVY R
Citation: Sj. Knox et al., RANDOMIZED CONTROLLED-STUDY OF I-131 ANTI-B1 VERSUS UNLABELED-ANTI-B1MONOCLONAL-ANTIBODY IN PATIENTS WITH CHEMOTHERAPY REFRACTORY LOW-GRADE NON-HODGKINS-LYMPHOMA, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 326-326
Authors:
MARQUEZ SD
KNOX SJ
TRISLER KD
GORIS ML
Citation: Sd. Marquez et al., HEMATOLOGICAL TOXICITY IN RADIOIMMUNOTHERAPY IS PREDICTED BOTH BY THECOMPUTED ABSORBED WHOLE-BODY DOSE (CGY) AND BY THE ADMINISTERED DOSE (MCI), International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 327-327
Authors:
KHAN WB
SHUI CX
NING SC
KNOX SJ
Citation: Wb. Khan et al., ENHANCEMENT OF MURINE INTESTINAL STEM-CELL SURVIVAL AFTER IRRADIATIONBY KERATINOCYTE GROWTH-FACTOR, Radiation research, 148(3), 1997, pp. 248-253
Authors:
NING SC
TRISLER K
WESSELS BW
KNOX SJ
Citation: Sc. Ning et al., RADIOBIOLOGICAL STUDIES OF RADIOIMMUNOTHERAPY AND EXTERNAL-BEAM RADIOTHERAPY IN-VITRO AND IN-VIVO IN HUMAN RENAL-CELL CARCINOMA XENOGRAFTS, Cancer, 80(12), 1997, pp. 2519-2528
Authors:
KNOX SJ
VARGHESE A
KHAN W
CHEN E
MACMANUS M
RAY G
LEE K
LAMBORN KR
Citation: Sj. Knox et al., A PROSPECTIVE-STUDY OF RADIATION THERAPY-ASSOCIATED THROMBOCYTOPENIA, Blood, 90(10), 1997, pp. 4237-4238
Authors:
GILBERT MS
RUPNOW BA
RAMIREZ DA
TRISLER KD
KNOX SJ
Citation: Ms. Gilbert et al., OVER-EXPRESSION OF BCL-2 PROTECTS AGAINST APOPTOSIS INDUCED BY THE BIOREDUCTIVE CYTOTOXIC DRUG SR4233 (TIRAPAZAMINE), Cell death and differentiation, 3(2), 1996, pp. 215-222
Authors:
KNOX SJ
GORIS ML
TRISLER K
NEGRIN R
DAVIS T
LILES TM
GRILLOLOPEZ A
CHINN P
VARNS C
NING SC
FOWLER S
DEB N
BECKER M
MARQUEZ C
LEVY R
Citation: Sj. Knox et al., YTTRIUM-90-LABELED ANTI-CD20 MONOCLONAL-ANTIBODY THERAPY OF RECURRENTB-CELL LYMPHOMA, Clinical cancer research, 2(3), 1996, pp. 457-470
Authors:
NING S
TRISLER K
BROWN DM
YU NY
KANEKAL S
LUNDSTEN MJ
KNOX SJ
Citation: S. Ning et al., INTRATUMORAL RADIOIMMUNOTHERAPY OF A HUMAN COLON-CANCER XENOGRAFT USING A SUSTAINED-RELEASE GEL, Radiotherapy and oncology, 39(2), 1996, pp. 179-189
Authors:
GILBERT MS
SAAD AH
RUPNOW BA
KNOX SJ
Citation: Ms. Gilbert et al., ASSOCIATION OF BCL-2 WITH MEMBRANE HYPERPOLARIZATION AND RADIORESISTANCE, Journal of cellular physiology, 168(1), 1996, pp. 114-122
Authors:
ALARCON RM
RUPNOW BA
GRAEBER TG
KNOX SJ
GIACCIA AJ
Citation: Rm. Alarcon et al., MODULATION OF C-MYC ACTIVITY AND APOPTOSIS IN-VIVO, Cancer research, 56(19), 1996, pp. 4315-4319
MULTIPLE COURSES OF HIGH-DOSE TOTAL SKIN ELECTRON-BEAM THERAPY IN THEMANAGEMENT OF MYCOSIS-FUNGOIDES
Authors:
BECKER M
HOPPE RT
KNOX SJ
Citation: M. Becker et al., MULTIPLE COURSES OF HIGH-DOSE TOTAL SKIN ELECTRON-BEAM THERAPY IN THEMANAGEMENT OF MYCOSIS-FUNGOIDES, International journal of radiation oncology, biology, physics, 32(5), 1995, pp. 1445-1449
Authors:
LEIGH BR
KHAN W
HANCOCK SL
KNOX SJ
Citation: Br. Leigh et al., STEM-CELL FACTOR ENHANCES THE SURVIVAL OF MURINE INTESTINAL STEM-CELLS AFTER PHOTON IRRADIATION, Radiation research, 142(1), 1995, pp. 12-15
Authors:
KNOX SJ
Citation: Sj. Knox, OVERVIEW OF STUDIES ON EXPERIMENTAL RADIOIMMUNOTHERAPY, Cancer research, 55(23), 1995, pp. 5832-5836
Authors:
SHUI CX
KHAN WB
LEIGH BR
TURNER AM
WILDER RB
KNOX SJ
Citation: Cx. Shui et al., EFFECTS OF STEM-CELL FACTOR ON THE GROWTH AND RADIATION SURVIVAL OF TUMOR-CELLS, Cancer research, 55(15), 1995, pp. 3431-3437
Authors:
LEIGH BR
WEBB S
HANCOCK SL
KNOX SJ
Citation: Br. Leigh et al., STEM-CELL FACTOR ENHANCES THE SURVIVAL OF IRRADIATED HUMAN BONE-MARROW MAINTAINED IN SCID MICE, Stem cells, 12(4), 1994, pp. 430-435
Authors:
KNOX SJ
FOWLER S
MARQUEZ C
HOPPE RT
Citation: Sj. Knox et al., EFFECT OF FILGRASTIM (G-CSF) IN HODGKINS-DISEASE PATIENTS TREATED WITH RADIATION, International journal of radiation oncology, biology, physics, 28(2), 1994, pp. 445-450
Authors:
WILDER RB
MCGANN JK
SUTHERLAND WR
WALLER EK
MINCHINTON AI
GORIS ML
KNOX SJ
Citation: Rb. Wilder et al., THE HYPOXIC CYTOTOXIN SR-4233 INCREASES THE EFFECTIVENESS OF RADIOIMMUNOTHERAPY IN MICE WITH HUMAN NON-HODGKINS-LYMPHOMA XENOGRAFTS, International journal of radiation oncology, biology, physics, 28(1), 1994, pp. 119-126
Authors:
KNOX SJ
SUTHERLAND W
GORIS ML
Citation: Sj. Knox et al., DETERMINANTS OF LOW-DOSE RATE EFFECTS ASSOCIATED WITH RADIOIMMUNOTHERAPY, Antibody immunoconjugates, and radiopharmaceuticals, 6(3), 1993, pp. 197-207